Ironwood Pharmaceuticals (IRWD) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $120.4 million.
- Ironwood Pharmaceuticals' Receivables - Net rose 5800.52% to $120.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.4 million, marking a year-over-year increase of 5800.52%. This contributed to the annual value of $81.9 million for FY2024, which is 3657.16% down from last year.
- As of Q3 2025, Ironwood Pharmaceuticals' Receivables - Net stood at $120.4 million, which was up 5800.52% from $86.2 million recorded in Q2 2025.
- Ironwood Pharmaceuticals' 5-year Receivables - Net high stood at $138.0 million for Q4 2021, and its period low was $39.8 million during Q1 2025.
- In the last 5 years, Ironwood Pharmaceuticals' Receivables - Net had a median value of $119.0 million in 2023 and averaged $106.3 million.
- As far as peak fluctuations go, Ironwood Pharmaceuticals' Receivables - Net soared by 52531.77% in 2021, and later crashed by 5117.65% in 2024.
- Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Receivables - Net stood at $138.0 million in 2021, then decreased by 5.8% to $130.0 million in 2022, then dropped by 0.68% to $129.1 million in 2023, then crashed by 36.57% to $81.9 million in 2024, then soared by 47.01% to $120.4 million in 2025.
- Its Receivables - Net stands at $120.4 million for Q3 2025, versus $86.2 million for Q2 2025 and $39.8 million for Q1 2025.